- Conditions
- Osteoarthritis
- Interventions
- Oral Salmon Calcitonin, Oral Salmon Calcitonin (Placebo)
- Drug
- Lead sponsor
- Nordic Bioscience A/S
- Industry
- Eligibility
- 51 Years to 80 Years
- Enrollment
- 1,030 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2011
- U.S. locations
- 6
- States / cities
- Tuscaloosa, Alabama • Sacramento, California • Chicago, Illinois + 3 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 337–360
of 914
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Knee Osteoarthritis, Knee Arthritis, Knee Pain Chronic, Knee Deformity, Knee Pain Swelling, Muscle Weakness, Muscle Weakness Condition, Power
- Interventions
- Manual Physical Therapy
- Procedure
- Lead sponsor
- Jennifer Moreno Clinic
- Other
- Eligibility
- 45 Years to 74 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020
- U.S. locations
- 1
- States / cities
- Fort Sam Houston, Texas
- Conditions
- Osteoarthritis, Knee, Knee Pain Chronic
- Interventions
- 6% aqueous phenol, Isotonic saline
- Drug
- Lead sponsor
- Kessler Foundation
- Other
- Eligibility
- 40 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- West Orange, New Jersey
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Lidoderm (Lidocaine 5% Patch), Placebo Patch
- Drug
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 37 Years and older
- Enrollment
- 169 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 20
- States / cities
- Paradise Valley, Arizona • Phoenix, Arizona • Milford, Connecticut + 16 more
- Conditions
- Knee Osteoarthritis
- Interventions
- Lorecivivint, Placebo
- Drug
- Lead sponsor
- Biosplice Therapeutics, Inc.
- Industry
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 499 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 44
- States / cities
- Tucson, Arizona • Cerritos, California • La Mesa, California + 35 more
- Conditions
- Osteoarthritis
- Interventions
- celecoxib, Oxycodone, placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 40 Years to 70 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 2
- States / cities
- Palo Alto, California • Stanford, California
- Conditions
- Knee Osteoarthritis
- Interventions
- Clinician-administered joint mobilization, Self-administered joint mobilization, Exercise-based physical therapy
- Other
- Lead sponsor
- Texas Woman's University
- Other
- Eligibility
- 45 Years and older
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 2
- States / cities
- Allen, Texas • Plano, Texas
- Conditions
- Arthropathy of Knee, Arthritis and/or Post-traumatic Degenerative Problems
- Interventions
- Optetrak PS, Optetrak Hi-Flex
- Device
- Lead sponsor
- Exactech
- Industry
- Eligibility
- 50 Years to 80 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 1
- States / cities
- Newport News, Virginia
- Conditions
- Osteoarthritis, Knee, Hypertension
- Interventions
- STAR Intervention, Attention-Control
- Behavioral
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 50 Years and older
- Enrollment
- 182 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Chronic Low Back Pain, Osteoarthritis
- Interventions
- Fasinumab, Placebo
- Drug
- Lead sponsor
- Regeneron Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 63 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 56
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Anaheim, California + 47 more
- Conditions
- Osteoarthritis, Knee
- Interventions
- Autologous adipose tissue injection, Hyaluronic Acid
- Biological · Drug
- Lead sponsor
- University of Southern California
- Other
- Eligibility
- 45 Years to 75 Years
- Enrollment
- 54 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Osteo Arthritis Knee, Osteoarthritis
- Interventions
- Total Knee Replacement
- Device
- Lead sponsor
- DePuy Orthopaedics
- Industry
- Eligibility
- 22 Years to 85 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 5
- States / cities
- Baltimore, Maryland • Crosby, Minnesota • Charlotte, North Carolina + 2 more
- Conditions
- Osteoarthritis, Knee
- Interventions
- Pentosan Polysulphate Sodium, Placebo (Sodium Chloride Injection, 0.9%)
- Drug
- Lead sponsor
- Paradigm Biopharmaceuticals Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 133 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Knee Osteoarthritis
- Interventions
- Arthroscopic debridement with stem cell transplantation, Arthroscopic debridement only
- Procedure
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 35 Years to 70 Years
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2025
- U.S. locations
- 3
- States / cities
- Santa Monica, California • Stanford, California • Denver, Colorado
- Conditions
- Knee Osteoarthritis
- Interventions
- Strength Training
- Other
- Lead sponsor
- Frederiksberg University Hospital
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Greenville, North Carolina
- Conditions
- Osteoarthritis, Knee
- Interventions
- Diclofenac, topical
- Drug
- Lead sponsor
- Nuvo Research Inc.
- Industry
- Eligibility
- 40 Years to 85 Years
- Enrollment
- 750 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2005
- U.S. locations
- 22
- States / cities
- Mobile, Alabama • Phoenix, Arizona • Beverly Hills, California + 19 more
- Conditions
- Postoperative Pain, Inflammation, Osteoarthritis
- Interventions
- Dexamethasone 10 mg, Dexamethasone 20 mg, Standard multimodal pain management regimen, Placebo
- Drug
- Lead sponsor
- Thomas L Bradbury
- Other
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Tucker, Georgia
- Conditions
- Osteoarthritis
- Interventions
- Omnibond Topical Skin Adhesive, Dermabond Advanced Topical Skin Adhesive
- Device
- Lead sponsor
- Center for Innovation and Research Organization
- Network
- Eligibility
- 18 Years and older
- Enrollment
- 310 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 4
- States / cities
- New York, New York • New Albany, Ohio • Philadelphia, Pennsylvania + 1 more
- Conditions
- Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
- Interventions
- Cebranopadol (GRT6005) Low-Dose Range, Cebranopadol (GRT6005) High-Dose Range, Placebo, Oxycodone CR
- Drug
- Lead sponsor
- Tris Pharma, Inc.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 619 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 83
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 74 more
- Conditions
- Knee Osteoarthritis, Knee Arthritis, Knee Pain Chronic
- Interventions
- MOTO Medial® UKA
- Device
- Lead sponsor
- Medacta USA
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 269 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2025
- U.S. locations
- 5
- States / cities
- Lady Lake, Florida • Louisville, Kentucky • Billings, Montana + 2 more
- Conditions
- Osteoarthritis, Knee
- Interventions
- Total Knee Arthroplasty using Manual Instrumentation, Total Knee Arthroplasty using Robotic Arm
- Device
- Lead sponsor
- Rothman Institute Orthopaedics
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 4
- States / cities
- Athens, Georgia • Egg Harbor, New Jersey • Cleveland, Ohio + 1 more
- Conditions
- Osteoarthritis, Inflammatory Arthritis
- Interventions
- Platelet Rich Plasma
- Biological
- Lead sponsor
- Exactech
- Industry
- Eligibility
- Not listed
- Enrollment
- 70 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2013
- U.S. locations
- 2
- States / cities
- Lewiston, Maine • Salisbury, Maryland
- Conditions
- Osteoarthritis
- Interventions
- Uniglide Mobile Bearing Unicondylar Knee System, Uniglide Fixed Bearing Unicondylar Knee System
- Device
- Lead sponsor
- Corin
- Industry
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 37 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2014
- U.S. locations
- 6
- States / cities
- La Quinta, California • Clearwater, Florida • Lexington, Kentucky + 3 more
- Conditions
- Osteoarthritis, Knee
- Interventions
- Vitamin D (cholecalciferol), Placebo
- Dietary Supplement
- Lead sponsor
- Tufts Medical Center
- Other
- Eligibility
- 45 Years to 90 Years
- Enrollment
- 146 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2009
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts